Gables Capital Management Inc. Jazz Pharmaceuticals PLC Transaction History
Gables Capital Management Inc.
- $204 Million
- Q4 2024
A detailed history of Gables Capital Management Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Gables Capital Management Inc. holds 36 shares of JAZZ stock, worth $3,700. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36
Previous 1,329
97.29%
Holding current value
$3,700
Previous $148,000
97.3%
% of portfolio
0.0%
Previous 0.08%
Shares
12 transactions
Others Institutions Holding JAZZ
# of Institutions
553Shares Held
59.2MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$632 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$620 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$260 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$228 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$209 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.44B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...